Yttrium-90-Induced Gastropathy: A Potential Equivocal Finding

Yttrium-90-Induced Gastropathy: A Potential Equivocal Finding

Bibliographic Details
Main Authors:	Rui Castro, Diogo Libânio, Pedro Heitor, Manuel Jácome, Rui Silva
Format:	Article
Language:	English
Published:	Karger Publishers 2020-04-01
Series:	GE: Portuguese Journal of Gastroenterology
Subjects:	colorectal cancer gastropathy selective internal radiation therapy yttrium-90
Online Access:	https://www.karger.com/Article/FullText/507202

Similar Items

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
by: Raval eMihir, et al.
Published: (2014-07-01)

Efficacy and safety of selective internal radiation therapy with yttrium-90 for the treatment of unresectable hepatocellular carcinoma
by: Nguyen Van Thai, et al.
Published: (2021-05-01)

Non-target activity detection by post-radioembolization yttrium-90 PET/CT: Image assessment technique and case examples
by: Yung Hsiang eKao, et al.
Published: (2014-02-01)

Yttrium-90 radioembolization for the treatment of unresectable liver cancer: Results of a single center
by: Özhan Özgür, et al.
Published: (2014-03-01)

Outcomes and predictors of toxicity after selective internal radiation therapy using yttrium-90 resin microspheres for unresectable hepatocellular carcinoma
by: Andrew eGabrielson, et al.
Published: (2015-12-01)

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings
by: Sagun Parakh, et al.
Published: (2016-07-01)

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
by: Mahvash A, et al.
Published: (2016-02-01)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
by: Aman Saini, et al.
Published: (2019-01-01)

Application of Ion-Exchange Resin Column for Basic Development of Strontium-90/Yttrium-90 Generator for Preparation of Radiopharmaceutical Therapy
by: Muchtaridi Muchtaridi, et al.
Published: (2017-04-01)

Yttrium-90 radioembolization in patients with hepatocellular carcinoma who have previously received sorafenib
by: Nitesh eRana, et al.
Published: (2013-12-01)

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
by: Cappelli A, et al.
Published: (2014-11-01)

Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization
by: Michael Köhler, et al.
Published: (2019-12-01)

Treatment response evaluation using Yttrium-90 in patients with rheumatoid arthritis of knee joint
by: Jong Min Kim, et al.
Published: (2018-01-01)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
by: Ron C. Gaba, et al.
Published: (2012-08-01)

Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study
by: Nichole M. Maughan, et al.
Published: (2018-04-01)

Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience
by: Julie Pellegrinelli, et al.
Published: (2021-01-01)

Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree
by: Joost W. Wijlemans, et al.
Published: (2011-07-01)

Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion
by: Nicholas Pigg, et al.
Published: (2020-02-01)

Efficacy and Safety of Rebamipide in Prevention of NSAID-Gastropathy
by: Serhiy Tkach, et al.
Published: (2017-03-01)

Long-Term Palliative Effect of Stenting in Gastric Outlet Obstruction Due to Transarterial Chemoembolization with Yttrium-90 in a Patient with Metastatic Neuroendocrine Tumor
by: Erkan Caglar, et al.
Published: (2016-09-01)

Yttrium-90 radioembolization in desmoplastic small round cell tumor with recurrent hepatic metastasis following hyperthermic intraperitoneal chemotherapy
by: Harkanwar Gill, MD, et al.
Published: (2021-06-01)

A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry following Radioembolization with Resin Microspheres
by: Alexander Samuel Pasciak, et al.
Published: (2014-05-01)

A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
by: Zhen Y, et al.
Published: (2019-06-01)

Upper GI Bleeding Secondary to Radiation Gastritis in a Patient with Preexisting Portal Hypertensive Gastropathy
by: Samragnyi Madala, et al.
Published: (2021-06-01)

Portal Hypertensive Gastropathy (Literature Review)
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

Helicobacter pylori Infection in Patients with Portal Hypertensive Gastropathy Owing to Liver Cirrhosis: Prevalence and Relation with Severity of Gastropathy
by: Shekhar Puri, et al.
Published: (2017-07-01)

Chemorefractory liver metastasis from cervical cancer successfully treated with a combination of yttrium-90 and immunotherapy
by: Michael E. Nance, et al.
Published: (2020-08-01)

NSAID GASTROPATHY: CHANGES OVER 12 YEARS
by: A E Karateev
Published: (2011-06-01)

Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
by: Sen Lu, et al.
Published: (2021-02-01)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01)

A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis
by: Zhongzhi Jia, et al.
Published: (2016-01-01)

Histopathological study of portal hypertensive gastropathy using gastric biopsy
by: Shirish S Chandanwale, et al.
Published: (2017-01-01)

Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis
by: Ibrahim F Amer, et al.
Published: (2021-02-01)

Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization
by: Minzhi Xing, et al.
Published: (2018-01-01)

THE PREVALENCE OF GASTROPATHIES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Derbak M. A., et al.
Published: (2020-12-01)

Severe bile duct complication after yttrium-90 radioembolization therapy in a patient with recurrent hepatocellular carcinoma after liver transplantation: A case report
by: Jian-Wen Zhang, et al.
Published: (2021-03-01)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
by: Hoda Rezaei Roshan, et al.
Published: (2015-01-01)

Management of portal hypertensive gastropathy and other bleeding
by: Woo Jin Chung
Published: (2014-03-01)

Comparison of the Biograph Vision and Biograph mCT for quantitative 90Y PET/CT imaging for radioembolisation
by: Britt Kunnen, et al.
Published: (2020-03-01)

Genistein attenuated gastric inflammation and apoptosis in Helicobacter pylori-induced gastropathy in rats
by: Prasong Siriviriyakul, et al.
Published: (2020-12-01)